Hypoxia reduces placental mTOR activation in a hypoxia-induced model of intrauterine growth restriction (IUGR)

Physiological Reports

Volumn 3, Issue 12, 2015, Pages

  Kimball, Rebecca ^a   Wayment, Montana ^a   Merrill, Daniel ^a   Wahlquist, Tyler ^a   Reynolds, Paul R ^a   Arroyo, Juan A ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

Hypoxia; IUGR; MTOR; Placenta; Trophoblast

Indexed keywords

INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN P70;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPSY; CONTROLLED STUDY; FEMALE; FETUS WEIGHT; GESTATION PERIOD; HYPOXIA; IMMUNOHISTOCHEMISTRY; INTRAUTERINE GROWTH RETARDATION; MALE; NONHUMAN; PLACENTA WEIGHT; PROTEIN ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; SPECTROPHOTOMETRY; TROPHOBLAST; UTERUS; WESTERN BLOTTING;

EID: 85006036890     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12651     Document Type: Article

References (43)

1. Ain, R., L. N. Canham, and M. J. Soares. 2005. Dexamethasone-induced intrauterine growth restriction impacts the placental prolactin family, insulin-like growth factor-II and the Akt signaling pathway. J. Endocrinol. 185:253–263.
2. Arroyo, J. A., R. V. Anthony, and H. L. Galan. 2008. Decreased placental X-linked inhibitor of apoptosis protein in an ovine model of intrauterine growth restriction. Am. J. Obstet. Gynecol. 199:80–88.
3. Arroyo, J. A., L. D. Brown, and H. L. Galan. 2009. Placental mammalian target of rapamycin and related signaling pathways in an ovine model of intrauterine growth restriction. Am. J. Obstet. Gynecol. 201:616 e611–616 e617.
4. Bahr, B. L., M. D. Price, D. Merrill, C. Mejia, L. Call, D. Bearss, et al. 2014. Different expression of placental pyruvate kinase in normal, preeclamptic and intrauterine growth restriction pregnancies. Placenta 35:883–890.
5. Blume-Jensen, P., and T. Hunter. 2001. Oncogenic kinase signalling. Nature 411:355–365.
6. Bourque, S. L., V. W. Dolinsky, J. R. Dyck, and S. T. Davidge. 2012. Maternal resveratrol treatment during pregnancy improves adverse fetal outcomes in a rat model of severe hypoxia. Placenta 33:449–452.
7. Brar, H. S., and S. E. Rutherford. 1988. Classification of intrauterine growth retardation. Semin. Perinatol. 12:2–10.
8. Caniggia, I., and J. L. Winter. 2002. Adriana and Luisa Castellucci Award lecture 2001. Hypoxia inducible factor-1: oxygen regulation of trophoblast differentiation in normal and pre-eclamptic pregnancies–a review. Placenta 23(Suppl. A):S47–S57.
9. Copps, K. D., and M. F. White. 2012. Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia 55:2565–2582.
10. Eriksson, A., R. Cao, R. Pawliuk, S. M. Berg, M. Tsang, D. Zhou, et al. 2002. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers. Cancer Cell 1:99–108.
11. Genbacev, O., Y. Zhou, J. W. Ludlow, and S. J. Fisher. 1997. Regulation of human placental development by oxygen tension. Science 277:1669–1672.
12. Giussani, D. A., and S. T. Davidge. 2013. Developmental programming of cardiovascular disease by prenatal hypoxia. J. Dev. Orig. Health Dis. 4:328–337.
13. Gray, P. H., M. J. O’Callaghan, J. M. Harvey, C. J. Burke, and D. J. Payton. 1999. Placental pathology and neurodevelopment of the infant with intrauterine growth restriction. Dev. Med. Child Neurol. 41:16–20.
14. Iqbal, W., and J. Ciriello. 2013. Effect of maternal chronic intermittent hypoxia during gestation on offspring growth in the rat. Am. J. Obstet. Gynecol. 209:564 e561–564 e569.
15. Ishihara, N., H. Matsuo, H. Murakoshi, J. B. Laoag-Fernandez, T. Samoto, and T. Maruo. 2002. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am. J. Obstet. Gynecol. 186:158–166.
16. Jang, E. A., L. D. Longo, and R. Goyal. 2015. Antenatal maternal hypoxia: criterion for fetal growth restriction in rodents. Front. Physiol. 6:176.
17. Jansson, N., J. Pettersson, A. Haafiz, A. Ericsson, I. Palmberg, M. Tranberg, et al. 2006. Down-regulation of placental transport of amino acids precedes the development of intrauterine growth restriction in rats fed a low protein diet. J. Physiol. 576:935–946.
18. Jiang, B., A. Kamat, and C. R. Mendelson. 2000. Hypoxia prevents induction of aromatase expression in human trophoblast cells in culture: potential inhibitory role of the hypoxia-inducible transcription factor Mash-2 (mammalian achaete-scute homologous protein-2). Mol. Endocrinol. 14:1661–1673.
19. Knuth, A., L. Liu, H. Nielsen, D. Merril, D. S. Torry, and J. A. Arroyo. 2014. Placenta growth factor induces invasion and activates p70 during rapamycin treatment in trophoblast cells. Am. J. Reprod. Immunol. 73:330–340.
20. Krebs, C., L. M. Macara, R. Leiser, A. W. Bowman, I. A. Greer, and J. C. Kingdom. 1996. Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. Am. J. Obstet. Gynecol. 175:1534–1542.
21. Lechuga, C. G., Z. H. Hernandez-Nazara, J. A. Dominguez Rosales, E. R. Morris, A. R. Rincon, A. M. Rivas-Estilla, et al. 2004. TGF-beta1 modulates matrix metalloproteinase- 13 expression in hepatic stellate cells by complex mechanisms involving p38MAPK, PI3-kinase, AKT, and p70S6k. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G974–G987.
22. Matheson, H., J. H. Veerbeek, D. S. Charnock-Jones, G. J. Burton, and H. W. Yung. 2015. Morphological and molecular changes in the murine placenta exposed to normobaric hypoxia throughout pregnancy. J. Physiol. doi:10.1113/JP271073.
23. Mayhew, T. M., C. Ohadike, P. N. Baker, I. P. Crocker, C. Mitchell, and S. S. Ong. 2003. Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. Placenta 24:219–226.
24. Milan, D., J. T. Jeon, C. Looft, V. Amarger, A. Robic, M. Thelander, et al. 2000. A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. Science 288:1248–1251.
25. Miled, N., Y. Yan, W. C. Hon, O. Perisic, M. Zvelebil, Y. Inbar, et al. 2007. Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit. Science 317:239–242.
26. Mura, M., T. G. Hopkins, T. Michael, N. Abd-Latip, J. Weir, E. Aboagye, et al. 2015. LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression. Oncogene 34:5025–5036.
27. Myatt, L. 2006. Placental adaptive responses and fetal programming. J. Physiol. 572:25–30.
28. Nelson, D. M., R. D. Johnson, S. D. Smith, E. Y. Anteby, and Y. Sadovsky. 1999. Hypoxia limits differentiation and upregulates expression and activity of prostaglandin H synthase 2 in cultured trophoblast from term human placenta. Am. J. Obstet. Gynecol. 180:896–902.
29. Pollack, R. N., and M. Y. Divon. 1992. Intrauterine growth retardation: definition, classification, and etiology. Clin. Obstet. Gynecol. 35:99–107.
30. Qian, X. J., Y. T. Li, Y. Yu, F. Yang, R. Deng, J. Ji, et al. 2015. Inhibition of DNA methyltransferase as a novel therapeutic strategy to overcome acquired resistance to dual PI3K/mTOR inhibitors. Oncotarget 6:5134–5146.
31. Rehman, G., A. Shehzad, A. L. Khan, and M. Hamayun. 2014. Role of AMP-activated protein kinase in cancer therapy. Arch. Pharm. 347:457–468.
32. Reyes, L. M., R. Kirschenman, A. Quon, J. S. Morton, A. Shah, and S. T. Davidge. 2015. Aerobic exercise training reduces cardiac function in adult male offspring exposed to prenatal hypoxia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 309: R489–R498.
33. Roos, S., N. Jansson, I. Palmberg, K. Saljo, T. L. Powell, and T. Jansson. 2007. Mammalian target of rapamycin in the human placenta regulates leucine transport and is downregulated in restricted fetal growth. J. Physiol. 582:449–459.
34. Roux, P. P., S. A. Richards, and J. Blenis. 2003. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity. Mol. Cell. Biol. 23:4796–4804.
35. Rueda-Clausen, C. F., J. L. Stanley, D. F. Thambiraj, R. Poudel, S. T. Davidge, and P. N. Baker. 2014. Effect of prenatal hypoxia in transgenic mouse models of preeclampsia and fetal growth restriction. Reprod. Sci. 21:492–502.
36. Shah, A., L. M. Reyes, J. S. Morton, D. Fung, J. Schneider, and S. T. Davidge. 2015. Effect of resveratrol on metabolic and cardiovascular function in male and female adult offspring exposed to prenatal hypoxia and a high-fat diet. J. Physiol. doi:10.1113/JP271133.
37. Soares, M. J., D. Chakraborty, M. A. Karim Rumi, T. Konno, and S. J. Renaud. 2012. Rat placentation: an experimental model for investigating the hemochorial maternal-fetal interface. Placenta 33:233–243.
38. Stapleton, D., K. I. Mitchelhill, G. Gao, J. Widmer, B. J. Michell, T. Teh, et al. 1996. Mammalian AMPactivated protein kinase subfamily. J. Biol. Chem. 271:611–614.
39. Tanaka, M., M. Natori, H. Ishimoto, T. Miyazaki, T. Kobayashi, and S. Nozawa. 1994. Experimental growth retardation produced by transient period of uteroplacental ischemia in pregnant Sprague-Dawley rats. Am. J. Obstet. Gynecol. 171:1231–1234.
40. Tapanainen, P. J., P. Bang, K. Wilson, T. G. Unterman, H. J. Vreman, and R. G. Rosenfeld. 1994. Maternal hypoxia as a model for intrauterine growth retardation: effects on insulin-like growth factors and their binding proteins. Pediatr. Res. 36:152–158.
41. Thorn, S. R., P. J. Rozance, L. D. Brown, and W. W. Hay Jr. 2011. The intrauterine growth restriction phenotype: fetal adaptations and potential implications for later life insulin resistance and diabetes. Semin. Reprod. Med. 29:225–236.
42. Trinh, X. B., W. A. Tjalma, P. B. Vermeulen, G. Van den Eynden, I. Van der Auwera, S. J. Van Laere, et al. 2009. The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer. Br. J. Cancer 100:971–978.
43. Wullschleger, S., R. Loewith, and M. N. Hall. 2006. TOR signaling in growth and metabolism. Cell 124:471–484.